BRIEF published on 03/26/2026 at 16:25, 21 days 9 hours ago Sartorius AG Extends René Fáber's Board Appointment Executive Board Sartorius AG Bioprocess Solutions Appointment Extension René Fáber
PRESS RELEASE published on 03/26/2026 at 16:20, 21 days 9 hours ago Sartorius AG Supervisory Board extends appointment of board member René Fáber Sartorius AG extends Dr. René Fáber's appointment on the Board until Dec 31, 2031, reinforcing the Bioprocess Solutions Division leadership. Learn more about Sartorius AG's latest decision here Supervisory Board Sartorius AG Appointment Extension René Fáber Bioprocess Solutions Division
BRIEF published on 03/26/2026 at 15:28, 21 days 10 hours ago Sartorius AG Concludes Annual General Meeting with Key Resolutions Financial Results Annual General Meeting Life Sciences Sartorius Dividends
PRESS RELEASE published on 03/26/2026 at 15:23, 21 days 10 hours ago Sartorius AG - Resolutions of the Annual General Meeting Sartorius AG's Annual General Meeting results approved dividend of 0.74 euros per preference share and 0.73 euros per ordinary share. Next financial reports in April, July, and October 2026 Annual General Meeting Dividend Financial Reports Biopharmaceutical Sartorius AG
BRIEF published on 03/17/2026 at 07:04, 30 days 19 hours ago Sartorius Intensifies Biopharma Strategy with Ambitious Growth Targets Operational Efficiency Growth Targets Bioprocess Solutions Sales Revenue Growth Biopharma Strategy
PRESS RELEASE published on 03/17/2026 at 06:59, 30 days 19 hours ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets at Capital Markets Day in Göttingen, Germany Sartorius Strategy Capital Markets Day Growth Targets Biopharma Focus
BRIEF published on 03/16/2026 at 14:09, 1 month ago Sartorius Unveils New Platform to Enhance Cell Therapy Production Cost Reduction Manufacturing Efficiency Cell Therapy Platform Eveo Launch Sartorius Innovation
PRESS RELEASE published on 03/16/2026 at 14:04, 1 month ago Sartorius launches next-generation platform to boost efficiency in cell therapy production Sartorius launches next-generation platform for efficient cell therapy production, enabling cost reduction and scalability. Integrated system addresses manufacturing challenges Sartorius Cell Therapy Production Efficiency Manufacturing Costs Eveo Platform
BRIEF published on 02/16/2026 at 10:41, 2 months ago Sartorius Enhances Climate Targets with SBTi Validation Net-zero Emissions Sartorius Sustainable Energy Science Based Targets Climate Targets
PRESS RELEASE published on 02/16/2026 at 10:36, 2 months ago Sartorius sharpens climate targets and receives validation from Science Based Targets initiative Sartorius sharpens climate targets with Science Based Targets initiative validation, aiming for net-zero emissions by 2045. Transitioning to renewable energy & sustainable practices Net-zero Emissions SBTi Sartorius Climate Targets Science-based
Published on 04/17/2026 at 02:00, 7 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 2 hours 35 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 4 hours 37 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 15:20, 10 hours 47 minutes ago Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026
Published on 04/16/2026 at 23:40, 2 hours 27 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 4 hours 30 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 5 hours 7 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 5 hours 32 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 6 hours 49 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 8 hours 5 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 8 hours 13 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
